title: Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a "dietary supplement".
authors.forename: F
authors.initials: F
authors.lastname: LoVecchio
authors.forename: S C
authors.initials: SC
authors.lastname: Curry
authors.forename: T
authors.initials: T
authors.lastname: Bagnasco
mesh_terms: D015107:4-Butyrolactone / Q000009:adverse effects*; D000328:Adult; D002490:Central Nervous System / Q000187:drug effects*; D003864:Depression, Chemical; D019587:Dietary Supplements / Q000009:adverse effects*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D008297:Male; D012890:Sleep; D012978:Sodium Oxybate / Q000009:adverse effects
chemical_list: D006993:Hypnotics and Sedatives; D012978:Sodium Oxybate; D015107:4-Butyrolactone